These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6327833)

  • 1. Biologic and immunologic characterization of the soluble skin-test antigen of varicella-zoster virus.
    Shiraki K; Yamanishi K; Takahashi M
    J Infect Dis; 1984 Apr; 149(4):501-4. PubMed ID: 6327833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections.
    Baba K; Shiraki K; Kanesaki T; Yamanishi K; Ogra PL; Yabuuchi H; Takahashi M
    J Clin Microbiol; 1987 Nov; 25(11):2193-6. PubMed ID: 2826535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect hemagglutination test for varicella-zoster infection.
    Furukawa T; Plotkin SA
    Infect Immun; 1972 Jun; 5(6):835-9. PubMed ID: 4344091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.
    Takayama M
    Med Microbiol Immunol; 1994 Feb; 183(1):1-11. PubMed ID: 8202026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superiority of varicella skin test antigen over purified varicella-zoster virus glycoproteins in monitoring booster response to Oka varicella vaccine.
    Sato H; Yamamura Ji; Kageyama S; Kurokawa M; Shiraki K
    Vaccine; 2003 Dec; 22(1):15-20. PubMed ID: 14604566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of antibodies to varicella-zoster virus by immune adherence hemagglutination.
    Wong CL; Castriciano S; Chernesky MA; Rawls WE
    J Clin Microbiol; 1978 Jan; 7(1):6-11. PubMed ID: 203604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response determined with antibody-dependent cell-mediated cytotoxicity (ADCC), neutralizing antibody, and varicella skin test in children with natural varicella and after varicella immunization.
    Ihara T; Kato T; Torigoe S; Oitani K; Isaji M; Ito M; Kamiya H; Sakura M
    Acta Paediatr Jpn; 1991 Feb; 33(1):43-9. PubMed ID: 1649540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed-type hypersensitivity and in vitro lymphocyte response in guinea pigs immunized with a live varicella vaccine.
    Shiraki K; Yamanishi K; Takahashi M; Dohi Y
    Biken J; 1984 Mar; 27(1):19-22. PubMed ID: 6091616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to early antigens of varicella-zoster virus during varicella and zoster.
    Gerna G; Cereda PM; Cattaneo E; Achilli G; Gerna MT
    J Infect Dis; 1979 Jul; 140(1):33-41. PubMed ID: 88490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster.
    Berger R; Luescher D; Just M; D'Hondt E; Bogaert H
    Postgrad Med J; 1985; 61 Suppl 4():137-41. PubMed ID: 3014471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement-fixing reactivity of Varicella-Zoster virus subunit antigens with sera from homotypic infections and heterotypic Herpes simplex virus infections.
    Schmidt NJ; Dennis J; Lennette EH
    Infect Immun; 1977 Mar; 15(3):850-4. PubMed ID: 192677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The etiologic agents of varicella and herpes zoster; serologic studies with the viruses as propagated in vitro.
    WELLER TH; WITTON HM
    J Exp Med; 1958 Dec; 108(6):869-90. PubMed ID: 13598817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to varicella-zoster virus glycoproteins in guinea pigs infected with Oka varicella vaccine.
    Sato H; Kageyama S; Imakita M; Ida M; Yamamura J; Kurokawa M; Shiraki K
    Vaccine; 1998 Aug; 16(13):1263-9. PubMed ID: 9682389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface antigens produced by Herpesviruses Varicella-Zoster virus.
    Ito M; Barron AL
    Infect Immun; 1973 Jul; 8(1):48-521. PubMed ID: 4352455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing antibody responses to varicella-zoster virus.
    Schmidt NJ; Lennette EH
    Infect Immun; 1975 Sep; 12(3):606-13. PubMed ID: 170206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative assay of varicella skin test antigens by the ELISA and RPHA tests.
    Shiraki K; Okuno T; Kato T; Yamanishi K; Takahashi M
    Acta Virol; 1990 Apr; 34(2):139-44. PubMed ID: 1975975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of immunity to varicella-zoster virus by means of an intradermal skin test.
    LaRussa P; Steinberg SP; Seeman MD; Gershon AA
    J Infect Dis; 1985 Nov; 152(5):869-75. PubMed ID: 2995511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assays for antibodies to varicella-zoster virus.
    Krah DL
    Infect Dis Clin North Am; 1996 Sep; 10(3):507-27. PubMed ID: 8856350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental infection and immune response of guinea pigs with varicella-zoster virus.
    Matsunaga Y; Yamanishi K; Takahashi M
    Infect Immun; 1982 Aug; 37(2):407-12. PubMed ID: 6288560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.